Technical development
Xemed collaborates with local area Universities and research centers in technical development of its hyperpolarized noble gas production systems and its chest coil development.
-
University of New HampshireDurham, New Hampshire, US
MagniXene® Imaging Network
Xemed collaborates with academic hospitals and medical research centers on the development of MagniXene® imaging protocols that are relevant for disease management and drug development.
-
Perelman School of MedicineUniversity of PennsylvaniaPhiladelphia, Pennsylvania, US
-
Washington University School of MedicineWashington University in St. LouisSt. Louis, Missouri, US
-
Thunder Bay Regional Health Research InstituteThunder Bay Regional Health Sciences CentreThunder Bay, Ontario, Canada
Past Collaborators
-
Athinoula A. Martinos CenterMassachusetts General HospitalCharlestown, Massachusetts, US
-
University of Virginia Health SystemCharlottesville, Virginia, US
-
Robarts Research InstituteUniversity of Western OntarioLondon, Ontario, Canada
Drug development
Xemed welcomes participation from pharmaceutical companies in the development of MagniXene® biomarkers for FDA qualification as a Drug Development Tool, to be used in staging and phenotyping disease of subjects enrolled in clinical trials and/or for assessing pharmacological activity of putative therapies.
-
(Name withheld)